Difference between revisions of "Williamson"

 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
  
−
== <span style="font-size: 140%;">No data on the use of hyperbaric oxygen for open tibial fractures</span> ==
+
<span style="line-height:normal">'''<span style="font-size:18.0pt"><span style="font-family:">No data on the use of hyperbaric oxygen for open tibial fractures</span></span>'''</span>
  
−
== '''<span style="font-size: 12pt;">Clinical bottom line:</span>''' ==
+
<span style="line-height:normal">'''<span style="font-size:14.0pt"><span style="font-family:">Clinical bottom line:</span></span>'''</span>
  
−
{|
+
{| class="Table" style="border:undefined"
 
|-
 
|-
−
| <span style="font-size:medium;">'''1. Trial abandoned having recruited only 17 patients in total (target 36 in each group)'''</span>
+
|  
 +
<span style="line-height:normal"><span style="font-size:14.0pt"><span style="font-family:">1. Trial abandoned having recruited only 17 patients in total (target 36 in each group)</span></span></span>
 +
 
 
|}
 
|}
  
−
<span style="font-size:medium;">'''Citation/s:'''''''''&nbsp;''''''1.&nbsp;Williamson OD, Millar I, Venturoni C. Hyperbaric oxygen and the management of open tibial fractures. Journal of Bone and Joint Surgery – British Volume, Orthopaedic proceedings 2005; 88-B(Suppl II):323.</span>
+
----
 +
 
 +
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Citation/s:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:">1. Williamson OD, Millar I, Venturoni C. Hyperbaric oxygen and the management of open tibial fractures. Journal of Bone and Joint Surgery – British Volume, Orthopaedic proceedings 2005; 88-B(Suppl II):323.</span></span></span>
  
−
<span style="font-size:medium;">'''Lead author's name and fax:''''''I. Millar&nbsp; I.Millar@alfred.org.au</span>
+
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Lead author's name and fax:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:">I. Millar I.Millar@alfred.org.au</span></span></span>
  
−
<span style="font-size:medium;">'''Three-part Clinical Question:''''''Does HBOT improve soft tissue healing in adult patients with open tibial fractures'''</span>
+
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Three-part Clinical Question:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:">Does HBOT improve soft tissue healing in adult patients with open tibial fractures?</span></span></span>
  
−
<span style="font-size:medium;">'''Search Terms:''' Open tibial fracture hyperbaric oxygen therapy</span>
+
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Search Terms:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:">Open tibial fracture; crush injury</span></span></span>
  
−
<span style="font-size:medium;">'''The Study:&nbsp;'''Non-blinded randomised controlled trial.</span>
+
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">The Study:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:">Non-blinded randomised controlled trial.</span></span></span>
  
−
<span style="font-size:medium;">The Study Patients:'''Adults with lower leg fractures requiring extensive soft tssue and/or vascular repair (Gustillo class 3B and 3C fractures).'''</span>
+
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">The Study Patients:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:">Adults with lower leg fractures requiring extensive soft tssue and/or vascular repair (Gustillo class 3B and 3C fractures).</span></span></span>
  
−
<span style="font-size:medium;">'''Control group''''''''':''' '''No HBOT, usual management.</span>
+
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Control group:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:">No HBOT, usual management.</span></span></span>
  
−
<span style="font-size:medium;">'''Experimental group''''''''':''''''As above plus HBOT – dose not reported</span>
+
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Experimental group:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:">As above plus HBOT – dose not reported.</span></span></span>
  
−
<span style="font-size:medium;">'''The Evidence:'''</span>
+
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">The Evidence:</span></span>'''</span>
  
−
<span style="font-size:medium;">None reported.</span>
+
<span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">None reported.</span></span></span>
  
−
<span style="font-size:medium;">'''Comments:'''</span>
+
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Comments:</span></span>'''</span>
  
−
<span style="font-size:medium;">1. Reasons for cancellation given were slower than expected recruitment rate and difficulty engaging orthopaedic team owing to pre-existing belief that HBO was efficacious.</span>
+
<span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">1. Reasons for cancellation given were slower than expected recruitment rate and difficulty engaging orthopaedic team owing to pre-existing belief that HBO was efficacious.</span></span></span>
  
−
<span style="font-size:medium;">2.No report of any outcome from the 17 enrolled patients.</span>
+
<span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">2. No report of any outcome from the 17 enrolled patients.</span></span></span>
  
−
<span style="font-size:medium;">'''Appraised by:''''''''''''Craig Wilson c.c.wilson@live.co.uk; Friday, 24 November 2017</span>
+
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Appraised by:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:">Craig Wilson c.c.wilson@live.co.uk; Friday, 24 November 2017</span></span></span>
  
−
<span style="font-size:medium;">'''Email:''' c.c.wilson@live.co.uk</span>
+
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Email:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:">c.c.wilson@live.co.uk</span></span></span>
  
−
<span style="font-size:medium;">'''Kill or Update By:''''''November 2022</span>
+
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Kill or Update By:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:">November 2022</span></span></span>
  
 
[[File:Sumhorsa.gif|center|sumhorsa.gif]]
 
[[File:Sumhorsa.gif|center|sumhorsa.gif]]
  
−
== <span style="display: block; text-align: center;"><span style="color: #7c00ff; font-size: 160%;">[[Acute_ischaemia|BACK]]</span></span> ==
+
== <span style="display: block; text-align: center;"><span style="color: #7c00ff; font-size: 160%;">[[Crush_injuries|BACK]]</span></span> ==
  
 
&nbsp;
 
&nbsp;

Latest revision as of 22:56, 23 August 2022

No data on the use of hyperbaric oxygen for open tibial fractures

Clinical bottom line:

1. Trial abandoned having recruited only 17 patients in total (target 36 in each group)


Citation/s:1. Williamson OD, Millar I, Venturoni C. Hyperbaric oxygen and the management of open tibial fractures. Journal of Bone and Joint Surgery – British Volume, Orthopaedic proceedings 2005; 88-B(Suppl II):323.

Lead author's name and fax:I. Millar I.Millar@alfred.org.au

Three-part Clinical Question:Does HBOT improve soft tissue healing in adult patients with open tibial fractures?

Search Terms:Open tibial fracture; crush injury

The Study:Non-blinded randomised controlled trial.

The Study Patients:Adults with lower leg fractures requiring extensive soft tssue and/or vascular repair (Gustillo class 3B and 3C fractures).

Control group:No HBOT, usual management.

Experimental group:As above plus HBOT – dose not reported.

The Evidence:

None reported.

Comments:

1. Reasons for cancellation given were slower than expected recruitment rate and difficulty engaging orthopaedic team owing to pre-existing belief that HBO was efficacious.

2. No report of any outcome from the 17 enrolled patients.

Appraised by:Craig Wilson c.c.wilson@live.co.uk; Friday, 24 November 2017

Email:c.c.wilson@live.co.uk

Kill or Update By:November 2022

sumhorsa.gif

BACK